LOS ANGELES, Feb. 19 (UPI) -- U.S. oncologists say a new class of targeted anti-cancer drugs shows promise in prolonging the lives of patients with recurrent prostate cancer.>>> Discuss This Story
LOS ANGELES, Feb. 19 (UPI) -- U.S. oncologists say a new class of targeted anti-cancer drugs shows promise in prolonging the lives of patients with recurrent prostate cancer.>>> Discuss This Story